He completed his PhD under David Gloriam in Copenhagen and an external stay at the MRC Laboratory of Otherwise it's just numbers and labels - and it becomes very quickly very meaningless." Alexander had a research sabbatical with Madan Babu at the MRC Laboratory of Molecular Biology in Cambridge

Arey’s laboratory discovered the first described synthetic agonists and antagonists of the FSHR and has

Celtarys Research develops high-quality, fluorescently labeled ligands and innovative chemical biology

He joined the laboratory of Dr. Stephen Ferguson’s laboratory in the Departments of Cellular & Molecular Medicine and Neuroscience at

well as practical guidance on handling, reconstitution, dilution, and storage to support immediate laboratory Enable high-specificity labeling of endogenous GLP-1R in live and fixed cells, pancreatic islets, and training who pursued postdoctoral studies at the CNRS in Montpellier before establishing his independent laboratory

He then received a prestigious Gates Cambridge Scholarship to study for a Ph.D. at the MRC Laboratory

He and his laboratory members studied the mechanisms of action and regulation of hormones and neurotransmitters

pancreatic beta cells before returning to the UK, first to her Department at UCL and then to lead a laboratory

Eddy began learning and investigating human GPCRs while training in the laboratories of Professors Raymond

Strategic Partner(s) Mark Schmeizl About Mark Schmeizl Mark leverages 30 years in various life science laboratories

His laboratory now explores how β₂-adrenergic receptor signaling can be manipulated to influence metabolism

Your Target of Interest Find Your Solutions The Human GPCRome - Obtain Your FREE Wall Poster for Your Laboratory

Arey’s laboratory discovered the first described synthetic agonists and antagonists of the FSHR and has

Her laboratory investigates marine-derived natural products with neuroactive properties, with particular

pharmacology at Imperial College London, and 17 years at the University of Auckland, where she led her own laboratory pharmacology of CGRP at CTR-RAMP1, suggest the drug may be less target-selective than its approval label

Brendan is now a final year PhD candidate in the Orphan Receptor Laboratory headed by Associate Professor

Richard Henderson at the Laboratory of Molecular Biology in Cambridge, UK.

She is a National Heart Foundation of Australia Future Leader Fellow and runs a laboratory of 7 Ph.D.